Back
Enlivex Therapeutics Vs. Compugen Industry Stock Comparison
Sell
32
ENLV
Enlivex Therapeutics
Last Price:
$1.19
Seasonality Move:
-21.95%
Sell
15
CGEN
Compugen
Last Price:
$1.59
Seasonality Move:
6.28%
Sell
32
Enlivex Therapeutics (ENLV)
is a Sell
Is Enlivex Therapeutics a Buy, Sell or Hold?
-
The current Enlivex Therapeutics [ENLV] share price is $1.19. The Score for ENLV is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
ENLV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ENLV Stock Price Chart
What is Enlivex Therapeutics's stock price today?
-
The Enlivex Therapeutics share price today is $1.19Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ENLV is experiencing slight selling pressure.
CGEN Stock Price Chart
ENLV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Buy |
Relative Strength Index (14 RSI): | 59.21 | Buy |
Chaikin Money Flow: | -201782 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.02 - 1.12) | Buy |
Bollinger Bands (100): | (1.04 - 1.36) | Sell |
CGEN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.12 | Sell |
Relative Strength Index (14 RSI): | 33.95 | Sell |
Chaikin Money Flow: | 204179 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.86 - 2.4) | Sell |
Bollinger Bands (100): | (1.49 - 2.13) | Sell |
ENLV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.1 | Buy |
20-day SMA: | 1.07 | Buy |
50-day SMA: | 1.13 | Buy |
200-day SMA: | 1.29 | Sell |
8-day EMA: | 1.11 | Buy |
20-day EMA: | 1.09 | Buy |
50-day EMA: | 1.12 | Buy |
200-day EMA: | 1.42 | Sell |
CGEN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.79 | Sell |
20-day SMA: | 2.07 | Sell |
50-day SMA: | 2.01 | Sell |
200-day SMA: | 1.85 | Sell |
8-day EMA: | 1.8 | Sell |
20-day EMA: | 1.97 | Sell |
50-day EMA: | 1.98 | Sell |
200-day EMA: | 1.86 | Sell |
Enlivex Therapeutics Earnings Growth & ENLV Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.07 per share, and a decrease next year of $0.01 per share.
Compugen Earnings Growth & CGEN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.06 per share, and an increase next year of $0.01 per share.
Enlivex Therapeutics Technical Analysis
Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
21 | 25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Compugen Technical Analysis
Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
21 | 25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |